ITMI20041447A1 - Composizione farmaceutica comprendente gabapentina - Google Patents

Composizione farmaceutica comprendente gabapentina

Info

Publication number
ITMI20041447A1
ITMI20041447A1 IT001447A ITMI20041447A ITMI20041447A1 IT MI20041447 A1 ITMI20041447 A1 IT MI20041447A1 IT 001447 A IT001447 A IT 001447A IT MI20041447 A ITMI20041447 A IT MI20041447A IT MI20041447 A1 ITMI20041447 A1 IT MI20041447A1
Authority
IT
Italy
Prior art keywords
gabapentina
pharmaceutical composition
composition including
pharmaceutical
including gabapentina
Prior art date
Application number
IT001447A
Other languages
English (en)
Inventor
Lazzari Alessandra De
Alessandro Grassano
Luca Rampoldi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT001447A priority Critical patent/ITMI20041447A1/it
Publication of ITMI20041447A1 publication Critical patent/ITMI20041447A1/it
Priority to CA2573985A priority patent/CA2573985C/en
Priority to US11/572,247 priority patent/US20080058420A1/en
Priority to AU2005263754A priority patent/AU2005263754B2/en
Priority to SI200531627T priority patent/SI1784174T1/sl
Priority to EA200700203A priority patent/EA012081B1/ru
Priority to CNA2005800271182A priority patent/CN101001621A/zh
Priority to JP2007521947A priority patent/JP5022896B2/ja
Priority to ES05774174T priority patent/ES2394506T3/es
Priority to NZ552673A priority patent/NZ552673A/en
Priority to EP05774174A priority patent/EP1784174B1/en
Priority to PCT/EP2005/053473 priority patent/WO2006008295A1/en
Priority to BRPI0513566A priority patent/BRPI0513566B8/pt
Priority to PT57741746T priority patent/PT1784174E/pt
Priority to PL05774174T priority patent/PL1784174T3/pl
Priority to DK05774174.6T priority patent/DK1784174T3/da
Priority to IL180631A priority patent/IL180631A/en
Priority to ZA200700511A priority patent/ZA200700511B/xx
Priority to HRP20120937TT priority patent/HRP20120937T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
IT001447A 2004-07-20 2004-07-20 Composizione farmaceutica comprendente gabapentina ITMI20041447A1 (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT001447A ITMI20041447A1 (it) 2004-07-20 2004-07-20 Composizione farmaceutica comprendente gabapentina
DK05774174.6T DK1784174T3 (da) 2004-07-20 2005-07-19 Famaceutisk sammensætning omfattende gabapentin
ES05774174T ES2394506T3 (es) 2004-07-20 2005-07-19 Composición farmacéutica que comprende gabapentina
EP05774174A EP1784174B1 (en) 2004-07-20 2005-07-19 A pharmaceutical composition comprising gabapentin
AU2005263754A AU2005263754B2 (en) 2004-07-20 2005-07-19 A pharmaceutical composition comprising gabapentin
SI200531627T SI1784174T1 (sl) 2004-07-20 2005-07-19 Farmacevtski sestavek vsebujoäś gabapentin
EA200700203A EA012081B1 (ru) 2004-07-20 2005-07-19 Фармацевтическая композиция, содержащая габапентин
CNA2005800271182A CN101001621A (zh) 2004-07-20 2005-07-19 包含加巴喷丁的药物组合物
JP2007521947A JP5022896B2 (ja) 2004-07-20 2005-07-19 ガバペンチン含有医薬組成物
CA2573985A CA2573985C (en) 2004-07-20 2005-07-19 A pharmaceutical composition comprising gabapentin
NZ552673A NZ552673A (en) 2004-07-20 2005-07-19 A stable pharmaceutical composition comprising gabapentin
US11/572,247 US20080058420A1 (en) 2004-07-20 2005-07-19 Pharmaceutical Composition Comprising Gabapentin
PCT/EP2005/053473 WO2006008295A1 (en) 2004-07-20 2005-07-19 A pharmaceutical composition comprising gabapentin
BRPI0513566A BRPI0513566B8 (pt) 2004-07-20 2005-07-19 composição farmacêutica compreendendo gabapentina
PT57741746T PT1784174E (pt) 2004-07-20 2005-07-19 Composição farmaceutica compreendendo gabapentina
PL05774174T PL1784174T3 (pl) 2004-07-20 2005-07-19 Kompozycja farmaceutyczna zawierająca gabapentynę
IL180631A IL180631A (en) 2004-07-20 2007-01-10 A stable pharmaceutical preparation containing gabapentin
ZA200700511A ZA200700511B (en) 2004-07-20 2007-01-17 A pharmaceutical composition comprising gabapentin
HRP20120937TT HRP20120937T1 (hr) 2004-07-20 2012-11-19 Farmaceutska smjesa koja sadrži gabapentin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001447A ITMI20041447A1 (it) 2004-07-20 2004-07-20 Composizione farmaceutica comprendente gabapentina

Publications (1)

Publication Number Publication Date
ITMI20041447A1 true ITMI20041447A1 (it) 2004-10-20

Family

ID=35106902

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001447A ITMI20041447A1 (it) 2004-07-20 2004-07-20 Composizione farmaceutica comprendente gabapentina

Country Status (19)

Country Link
US (1) US20080058420A1 (it)
EP (1) EP1784174B1 (it)
JP (1) JP5022896B2 (it)
CN (1) CN101001621A (it)
AU (1) AU2005263754B2 (it)
BR (1) BRPI0513566B8 (it)
CA (1) CA2573985C (it)
DK (1) DK1784174T3 (it)
EA (1) EA012081B1 (it)
ES (1) ES2394506T3 (it)
HR (1) HRP20120937T1 (it)
IL (1) IL180631A (it)
IT (1) ITMI20041447A1 (it)
NZ (1) NZ552673A (it)
PL (1) PL1784174T3 (it)
PT (1) PT1784174E (it)
SI (1) SI1784174T1 (it)
WO (1) WO2006008295A1 (it)
ZA (1) ZA200700511B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230031B1 (hu) * 2010-03-01 2015-05-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
US20140179784A1 (en) * 2012-12-21 2014-06-26 Mylan Inc. Levothyroxine formulation with carrageenan
US9271951B2 (en) 2012-12-21 2016-03-01 Mylan Inc. Levothyroxine formulation with acacia
US20150328246A1 (en) * 2014-05-16 2015-11-19 Vivus, Inc. Orally administratable formulations for the controlled release of a pharmacologically active agent
WO2016075704A2 (en) * 2014-11-15 2016-05-19 Eris Lifesciences Pvt Ltd. Stable topical pharmaceutical compositions comprising gabapentin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928183A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
EP1169060B1 (en) * 1999-04-09 2005-08-31 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US6294198B1 (en) * 1999-08-24 2001-09-25 Purepac Pharmaceutical Co. Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
JP4438268B2 (ja) * 2001-03-07 2010-03-24 大日本住友製薬株式会社 薬物顆粒の製造方法、および薬物顆粒、ならびにそれを用いた医薬製剤
JP2005533100A (ja) * 2002-07-10 2005-11-04 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー Ｇａｂａ誘導体を含む胃腸用組成物
US20040010035A1 (en) * 2002-07-15 2004-01-15 Ciociola Arthur A. Gastrointestinal compositions
CA2395931A1 (en) * 2002-08-07 2004-02-07 Bernard Charles Sherman Solid compositions comprising gabapentin having improved stability
US20040092522A1 (en) * 2002-08-15 2004-05-13 Field Mark John Synergistic combinations
GB0219024D0 (en) * 2002-08-15 2002-09-25 Pfizer Ltd Synergistic combinations
WO2005046566A2 (en) * 2003-08-04 2005-05-26 Sun Pharmaceutical Industries Limited Stable gabapentin containing composition

Also Published As

Publication number Publication date
WO2006008295A1 (en) 2006-01-26
EA200700203A1 (ru) 2007-06-29
PT1784174E (pt) 2012-12-17
BRPI0513566B1 (pt) 2019-09-10
AU2005263754A1 (en) 2006-01-26
CA2573985A1 (en) 2006-01-26
NZ552673A (en) 2011-03-31
PL1784174T3 (pl) 2013-01-31
US20080058420A1 (en) 2008-03-06
EA012081B1 (ru) 2009-08-28
SI1784174T1 (sl) 2013-01-31
CN101001621A (zh) 2007-07-18
EP1784174A1 (en) 2007-05-16
DK1784174T3 (da) 2012-12-10
ZA200700511B (en) 2008-09-25
JP2008506751A (ja) 2008-03-06
IL180631A (en) 2012-08-30
HRP20120937T1 (hr) 2012-12-31
BRPI0513566B8 (pt) 2021-05-25
AU2005263754B2 (en) 2010-09-23
IL180631A0 (en) 2008-04-13
CA2573985C (en) 2013-02-05
EP1784174B1 (en) 2012-09-05
BRPI0513566A (pt) 2008-05-06
JP5022896B2 (ja) 2012-09-12
ES2394506T3 (es) 2013-02-01

Similar Documents

Publication Publication Date Title
BRPI0511900A (pt) composições farmacêuticas
RU2398586C3 (ru) Фармацевтическая композиция
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
NO20075628L (no) Farmasøytiske formuleringer
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BRPI0613033A2 (pt) composição oral
BRPI0715712A2 (pt) Composição farmacêutica
DK1957073T3 (da) Lægemiddel
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
DK1962873T3 (da) Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier
BRPI0719393A2 (pt) Composição farmacêutica
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
DE602005016978D1 (de) Quecksilberfreisetzende Zusammensetzungen
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
DK1587478T3 (da) Farmaceutisk sammensætning
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
MA28801B1 (fr) Composition antihistaminique
BRPI0614413A2 (pt) composto, e, composição farmacêutica
BRPI0614412A2 (pt) composto, e, composição farmacêutica
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin
ITMI20042232A1 (it) Composizione farmaceutica contenente clozapina